Exploring the Potential of Nutraceuticals in Diabetic Retinopathy: Evidence-Based Mechanisms and Clinical Insights

Abstract

Diabetic retinopathy (DR) is a microvascular consequence of diabetes. Even in the early stages of diabetic retinopathy, oxidative stress can cause damage to retinal vascular endothelial cells. However, in individuals with  early-stage DR, effective care is required before the disease progresses to the more serious sight-threatening proliferative stage. This study explores the potential of nutraceuticals in the treatment of DR, focusing on their mechanisms of action as supported by evidence, clinical studies, and commercially accessible formulations. A thorough literature review was conducted to identify relevant research papers and reviews on nutraceuticals for the treatment of diabetic retinopathy. Relevant papers were located using scientific databases such as PubMed, Google Scholar, Elsevier, MDPI, ScienceDirect, and Web of Science. The search includes publications published up to November 2024 that used the standard keywords "Diabetic Retinopathy," "Nutraceuticals," "Evidence-Based Management," "Current Treatments," "Prevention," "Experimental Evidence," "Mechanisms of Action," "Marketed Formulations," "Clinical Studies," and "Future Directions." Nutraceuticals, which are natural functional foods with little adverse effects, have been advocated as therapeutic to people with DR. Many studies, both in vitro and in vivo, have established the benefits of a variety of nutraceuticals in DR, including their antioxidative, anti-inflammatory, neuroprotective, and vasoprotective activities. However, just a few clinical trials have been done, with varying results. Nutraceuticals, which combine natural ingredients with pharmaceutical chemicals, offer therapeutic potential in pathological situations such as DR. Although the findings are confined to animal models and have little bioavailability, they might provide a natural alternative to conventional therapies. Nutraceuticals may protect neurones, enhance retinal function, and activate pathways such as NF-κB and HIF-1α signalling. Diabetes-induced oxidative stress has been shown to increase inflammation and neurodegeneration, resulting in VEGF overexpression and vascular damage. Regardless of its preclinical character, research into interventive nutraceutical treatment may provide encouraging results in clinical applications.